Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-04
2006-07-04
Caputa, Anthony C. (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S024100
Reexamination Certificate
active
07071171
ABSTRACT:
Novel genes expressed selectively by long-term dendritic cell (DC) lines (XS series) from murine epidermis which retain important features of resident epidermal Langerhans cells (LC) are provided. These genes encode distinct type II membrane-integrated polypeptides, each consisting of a cytoplasmic domain, a transmembrane domain, an extracellular connecting domain, and a C-terminal extracellular domain that exhibits significant homology to the carbohydrate recognition domains (CRD)) of C-type lectins. Expression of both genes is highly restricted to cells of DC lineage (including epidermal LC). Thus, these genes encode new, DC-specific members of the C-type lectin family, now termed “DC-associated C-type lectin-1 and -2” (dectin-1 and dectin-2). Two isoforms of the dectin-1 molecule and five isoforms of the dectin-2 molecule have also been identified. The invention further provides His-tagged fusion proteins comprising 6x histidine and the extracellular domain of dectin-1 or dectin-2. Also provided are antibodies raised to synthetic peptides designed from the dectin-1 sequence or to the His-tagged fusion proteins described.
REFERENCES:
patent: 5199942 (1993-04-01), Gillis
patent: 5434340 (1995-07-01), Krimpenfort et al.
patent: 5530179 (1996-06-01), Terhorst et al.
patent: 5557032 (1996-09-01), Mak
patent: WO 96/23882 (1992-08-01), None
patent: WO 98/02456 (1998-01-01), None
Davis et al, “Direct gene transfer into skeletal muscle . . . ”, Hum Gene Therapy, vol. 4, pp. 151-159, Apr. 1993.
Panelli et al, “Phase 1 study in patients . . . ”, J Immunotherapy, vol. 23, pp. 487-498, 2000.
Bernhard et al, “Dendritic cells lose ability to present protein antigen . . . ”, Immunobiology, vol. 201, pp. 568-582, Apr. 2000.
Turley et al, “Transport of peptide-MHC class II complexes in developing dendritic cells”, Science, vol. 288, pp. 522-527, Apr. 2000.
Rodriquez et al, “Selective transport of internalized antigens to the cytosol . . . ”, Nat. Cell Biol., vol. 1, pp. 362-368, Oct. 1999.
Komatsubare et al, “Immortalization of murine leukocytes by oncogenes”, Microbiology and Immunology, 1988, vol. 32, pp. 869-875.
Dietz et al, “High efficiency adenovirus-mediated gene transfer to human dendritic cells”, Blood, 1998, vol. 91, pp. 392-398.
Paul, W. E., Fundamental Immunology, third edition, Raven Press, NY, 1993.
Lopez-Cabrera et al, “Transcriptional Regulation of the Gene Encoding the Human C-type Lectin Receptor AIM/CD69 and the Functional Characterization of Its Tumor Necrosis Factor-alpha Responsive Elements.” Journal of Biological Chemistry, vol. 270, No. 37, Sep. 1995.
Bieber et al, “CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells.”, Journal of Investigative Dermatology, vol. 98, No. 5, pp. 771-776, May 1992.
Zitvogel et al, “II-12-Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivo.”, Ann NY Acad Sci, vol. 795, pp. 284-293, Oct. 1996.
Rothmann et al, “Heart muscle-specific gene expression using replication defective recombinant adenovirus.”, Gene therapy, vol. 3, No. 10, pp. 919-926, Oct. 1996.
Ariizumi, et al., “Cloning of Novel C-Type Lectins That Are Expressed Selectively By Dendritic Cells,”The Journal of Investigative Dermatology,106(4):814, Abstract No. 52, Apr. 1996.
Benzouska, “C-Type Lectins of Natural Killer Cells: Carbohydrate Ligands and Role in Tumor Cell Lysis,”Biochemical Society Transactions,24:156-161, 1996.
Benzouska et al., “Rat Natural Killer Cell Antigen, NKR-P1, Related to C-Type Animal Lectins Is a Carbohydrate-Binding Protein,”The Journal of Biological Chemistry,269(24):16945-16952, Jun. 1994.
Chang et al., “Molecular Characterization of Human CD94: A Type II Membrane Glycoprotein Related to the C-Type Lectin Superfamily,”Eur. J. Immunol.,25:2433-2437, 1995.
Cherayil, Weiner and Pillai, “ The Mac-2 Antigen Is a Galactose-Specific Lectin That Binds IgE,”J. Exp. Med.,170:1959-1972, Dec. 1989.
Erard et al., “Interleukin 2 Is Both Necessary and Sufficient For the Growth and Differentiation of Lectin-Stimulated Cytolytic T Lymphocyte Precursors,”The Journal of Immunology,134(3):1644-1652, Mar. 1985.
Ezekowitz et al., “A Human Mannose-Binding Protein Is an Acute-Phase Reactant That Shares Sequence Homology with other Vertebrate Lectins,”J. Exp. Med.,167:1034-1046, Mar. 1988.
Hamann et al., “Expression Cloning of the Early Activation Antigen CD69, A Type II Intgral Membrane protein with a C-Type Lectin Domain,”The Journal of Immunology,150(11):4920-4927, Jun. 1993.
Lanier et al., “A Disulfide_Linked Homodimer of the C-Type Lectin Superfamily Expressed by a Subset of NK and T Lymphocytes,”The Journal of Immunology,153:2417-2428, 1994.
Licastro et al., “Lectins and Superantigens: Membrane Interactions of These Compounds with T Lymphocytes Affect Immune Responses,”Int. J. Biochem.,25(6):845-852, 1993.
López-Cabrera et al., “Molecular Cloning, Expression, and Chromosomal Localization of the Human Earliest Lymphocyte Activation Antigen AIM/CD69, a New Member of the C-Type Animal Lectin Superfamily of Signal Transmitting Receptors,”J. Exp. Med.,178:537-547, Aug. 1993.
Roosnek et al., “T Cell Triggering By Lectins II. Stimuli For Induction of Interleukin 2 Responsiveness and Interleukin 2 Production Differ Only in Quantitative Aspects,”Eur. J. Immunol.,15:657-661, 1985.
Sowalsky and Fox, “Pattern of Lectin Binding to Murine T Lymphocytes,”Immunology,75:92-98, 1992.
Steinman and Swanson, “The Endocytic Activity of Dendritic Cells,”J. Exp. Med.,182:283-288, Aug. 1995.
Suzuki et al., “Molecular Cloning and Expression of cDNA Encoding Human Macrophage C-Type Lectin,”The Journal of Immunology,156:128-135, 1996.
Ariizumi Kiyoshi
Takashima Akira
Board of Regents the University of Texas System
Canella Karen A.
Caputa Anthony C.
Fulbright & Jaworski L.L.P.
LandOfFree
Unique dendritic cell-associated c-type lectins, dectin-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unique dendritic cell-associated c-type lectins, dectin-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unique dendritic cell-associated c-type lectins, dectin-1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569283